Lars Kaestner Selected Research

Vascular Remodeling

9/2006

Reduced cardiac L-type Ca2+ current in Ca(V)beta2-/- embryos impairs cardiac development and contraction with secondary defects in vascular maturation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Kaestner Research Topics

Disease

5	Hemolysis 07/2020 - 01/2013
4	Channelopathies 01/2023 - 01/2020
4	Neuroacanthocytosis 01/2022 - 01/2021
4	Cardiac Arrhythmias (Arrythmia) 11/2016 - 06/2012
3	hereditary Xerocytosis 01/2023 - 01/2019
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 05/2013
3	Anemia 01/2021 - 01/2017
2	Hypoxia (Hypoxemia) 01/2024 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 02/2022
2	Hereditary Spherocytosis 01/2020 - 01/2019
2	Thalassemia 01/2019 - 05/2013
2	Heart Diseases (Heart Disease) 01/2016 - 07/2013
2	Hypertrophy 09/2015 - 07/2013
1	Congenital Hemolytic Anemia (Hemolytic Anemia, Congenital) 12/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Communicable Diseases (Infectious Diseases) 12/2022
1	COVID-19 12/2022
1	Infections 01/2021
1	Pain (Aches) 01/2020
1	Pyruvate Kinase Deficiency of Red Cells 01/2019
1	Glucosephosphate Dehydrogenase Deficiency 01/2019
1	Hemolytic Anemia 01/2019
1	Sinus Tachycardia 11/2016
1	Ischemia 11/2016
1	Thromboembolism 10/2016
1	Cardiomegaly (Heart Hypertrophy) 09/2015
1	Fibrosis (Cirrhosis) 09/2015
1	Genomic Instability 10/2012
1	Amyloid Plaque 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Atrial Fibrillation 08/2010
1	Neoplasms (Cancer) 10/2008
1	Melanoma (Melanoma, Malignant) 10/2008
1	Testicular Neoplasms (Testicular Cancer) 10/2008
1	Vascular Remodeling 09/2006
1	Heart Failure 09/2006
1	Thrombosis (Thrombus) 12/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2006
3	Ion Channels (Ion Channel)IBA 01/2022 - 01/2020
3	CalciumIBA 01/2017 - 12/2004
2	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
2	PhosphatidylserinesIBA 12/2023 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2021
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 12/2021
2	EnzymesIBA 01/2019 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 11/2016 - 10/2016
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2024
1	Blood Group Antigens (Blood Groups)IBA 01/2024
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2023
1	SuspensionsIBA 12/2022
1	LithiumIBA 01/2022
1	Erythropoietin FDA Link 01/2022
1	nasIBA 01/2022
1	lysophosphatidic acidIBA 01/2021
1	SmokeIBA 01/2021
1	senicapocIBA 01/2021
1	voltage-dependent calcium channel (P-Q type)IBA 01/2021
1	Memantine (Namenda)FDA Link 07/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2020
1	SpectrinIBA 01/2019
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2019
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2019
1	Glutamate-Cysteine LigaseIBA 01/2019
1	AnkyrinsIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	SiliconIBA 01/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2016
1	AldosteroneIBA 10/2016
1	Hormones (Hormone)IBA 01/2016
1	CationsIBA 09/2015
1	Atrial Natriuretic Factor (ANF)IBA 09/2015
1	ReninIBA 09/2015
1	LipidsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	PhosphofructokinasesIBA 05/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Amyloid beta-PeptidesIBA 01/2012
1	GangliosidesIBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	Monomeric GTP-Binding ProteinsIBA 08/2010
1	EpitopesIBA 10/2008
1	AntigensIBA 10/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2008
1	HLA-A*02:01 antigenIBA 10/2008
1	Dinoprostone (PGE2)FDA Link 12/2004
1	Prostaglandins EIBA 12/2004
1	zinc 1,4,8,11,15,18,22,25- octa- n- butoxyphthalocyanineIBA 06/2003

Therapy/Procedure

1	Therapeutics 12/2022
1	Hemodiafiltration 01/2022
1	Fluid Therapy (Oral Rehydration Therapy) 07/2020
1	Precision Medicine 01/2020